Conference Coverage
Conference Coverage
Dubious diagnosis: Is there a better way to define ‘prediabetes’?
There have been major increases in prediabetes in the United States and globally over the past 2 decades.
Conference Coverage
Cognitive behavioral therapy app lowers A1c in type 2 diabetes
People with type 2 diabetes who used a smartphone app for cognitive behavioral therapy had a significant drop in their A1c levels.
Latest News
Consider quality of life, comorbidities in hidradenitis suppurativa
Expert shares tips to optimize management of this challenging condition.
Conference Coverage
Diabetes and Heart Disease Highlights From the American Heart Association's Scientific Sessions 2022
Key abstracts related to diabetes and heart disease from AHA 2022 include a meta-analysis of cardiovascular results from...
Feature
Highly processed foods ‘as addictive’ as tobacco
New research suggests that health care professionals are taking steps toward framing food addiction as a clinical entity in its own right.
Conference Coverage
Patients trying to lose weight overestimate their diet quality
Only 28% of participants in a study had “good agreement” between their perceived diet quality and its actual quality.
Conference Coverage
Be aware, mindfulness training can lower systolic BP: MB-BP
“This is exactly what we need: a well-done trial with a control group to show that it actually works,” said one expert, cautioning that it...
From the Journals
More weight loss with surgery than new obesity meds: meta-analysis
“This is an exciting period because, 10 years ago, nobody thought that [results with] pharmacotherapy can approach bariatric surgery.”
Conference Coverage
Baxdrostat slashes BP in resistant hypertension: BrigHTN
The novel agent lowers aldosterone activity without the off-target inhibition of cortisol synthesis that has thwarted previous drug candidates,...
Conference Coverage
Is there a doctor on the plane? Tips for providing in-flight assistance
Tools in a physician’s in-flight toolbox start with the first-aid kit.
Conference Coverage
Sham-controlled renal denervation trial for hypertension is a near miss
The SPYRAL HTN–ON MED trial missed its primary endpoint, likely caused in part by imbalances in medication use.